NCT02926573 · OUTCOME

Patient Reported Post-treatment Pain Satisfaction as Measured by How Often the Participant's Pain Was Well Controlled

Perioperative Gabapentin Use In Head And Neck Mucosal Surgery Patients · Source last updated 2018-08-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure: COUNT_OF_PARTICIPANTS
Unit: Participants
Interval / dispersion: Not reported
Time frame: Once on post-op day 2 or day of discharge, whichever comes first

What was measured

-A discharge survey to document patient satisfaction and perceived pain control was given at the time of the last VAS score.

Analysis population: The participants who did not answer this question on the survey were not evaluable for this outcome measure.

Groups in this outcome

Gabapentin

Gabapentin liquid by mouth or per Tube 300mg twice a day

Placebo

Placebo liquid by mouth or Per Tube twice a day

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Gabapentin	42
Placebo	43

Reported measurements

Source class 1

Never

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Gabapentin	1	Not reported	Not reported	Not reported	Not reported
Placebo	0	Not reported	Not reported	Not reported	Not reported

Sometimes

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Gabapentin	1	Not reported	Not reported	Not reported	Not reported
Placebo	6	Not reported	Not reported	Not reported	Not reported

Usually/Always

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Gabapentin	40	Not reported	Not reported	Not reported	Not reported
Placebo	37	Not reported	Not reported	Not reported	Not reported

Source statistical analyses

Group order, estimate direction, methods and comments are retained. No treatment ranking is inferred.

ci Lower Limit
-3.0
ci Num Sides
TWO_SIDED
ci Pct Value
95
ci Upper Limit
21
group Ids
OG000
OG001
non Inferiority Type
SUPERIORITY
param Type
Percent Difference
param Value
9.2

Complete source fields

analyses

ci Lower Limit
-3.0
ci Num Sides
TWO_SIDED
ci Pct Value
95
ci Upper Limit
21
group Ids
OG000
OG001
non Inferiority Type
SUPERIORITY
param Type
Percent Difference
param Value
9.2

classes

categories
measurements
group Id
OG000
value
1
group Id
OG001
value
0
title
Never
measurements
group Id
OG000
value
1
group Id
OG001
value
6
title
Sometimes
measurements
group Id
OG000
value
40
group Id
OG001
value
37
title
Usually/Always

denoms

counts
group Id
OG000
value
42
group Id
OG001
value
43
units
Participants

description

-A discharge survey to document patient satisfaction and perceived pain control was given at the time of the last VAS score.

groups

description
Gabapentin liquid by mouth or per Tube 300mg twice a day
id
OG000
title
Gabapentin
description
Placebo liquid by mouth or Per Tube twice a day
id
OG001
title
Placebo

param Type

COUNT_OF_PARTICIPANTS

population Description

The participants who did not answer this question on the survey were not evaluable for this outcome measure.

reporting Status

POSTED

time Frame

Once on post-op day 2 or day of discharge, whichever comes first

title

Patient Reported Post-treatment Pain Satisfaction as Measured by How Often the Participant's Pain Was Well Controlled

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice